Mikroiğneleme için Alopecia Areata
A32 çalışmaya (1 meta-analysis, 9 RCTs), toplam 1,908 katılımcıyla dayanmaktadır. 25/32 çalışma olumlu etkiler göstermektedir.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dmicroneedling\u0026condition\u003Dalopecia\u002Dareata';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
Sonuç
Microneedling has strong evidence for supporting hair regrowth in alopecia areata, especially when combined with topical medications, and is backed by multiple randomized controlled trials.
- 25 out of 32 studies show positive effects, with 9 RCTs providing robust evidence
- Works by creating micro-injuries that stimulate healing responses and improve drug absorption
- Most effective when combined with topical agents like corticosteroids or vitamin D3
- Both professional clinical procedures and at-home derma rollers have been studied
Key Study Findings
scoping_review
n=16
A Scoping Review of Exosome Delivery Applications in Hair Loss.
Dose: variable; exosomes predominantly from mesenchymal stem cells (MSCs)
vs: Placebo
Etki: None
None
retrospective cohort
n=7
Open-label
Combination Therapy With CGF and Microneedling-Assisted Compound Betamethasone for Resistant Alopecia Areata: A Pilot Study.
Dose: Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip
vs: Placebo
Etki: 85.7% achieved complete recovery; 14.3% achieved >50% regrowth; significant SALT score improvement
None
Review
Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven …
Dose: None
vs: Placebo
Etki: None
None
randomized controlled trial
n=24
18 weeks
Open-label
A Comparative Clinical and Trichoscopic Study Between Fractional Radiofrequency Microneedling Versus Intralesional Steroids in Treatment …
Dose: Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals
vs: Placebo
Etki: Comparable efficacy between FRM and ILCS; nonsignificant differences in trichoscopic scores, PGA, an
None
review
The role of microtrauma in hair regrowth and regeneration in non-scarring alopecia.
Dose: Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera
vs: Placebo
Etki: Positive outcomes reported for hair density and thickness with microneedling, lasers, LLLT, and PRP
None
animal study
2 weeks
Investigating the potential mechanism of microneedling in alopecia areata mice based on 16S rRNA sequencing …
Dose: Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment
vs: Placebo
Etki: Microneedling enhanced hair growth; restored gut microbiome diversity; reduced acetic acid and propa
None
Key Statistics
34
Çalışmalar
1908
Katılımcılar
↑
Positive
A
Derece
Referenced Papers
Cureus
2025
7 atıf
Aesthetic plastic surgery
2025
2 atıf
Journal of cosmetic …
2025
1 atıf
Italian journal of …
2025
Dermatology reports
2025
Dermatologic surgery : …
2025
Frontiers in microbiology
2025
Lasers in medical …
2024
10 atıf
Skin appendage disorders
2024
5 atıf
PloS one
2024
4 atıf
Skin research and …
2024
3 atıf
The Journal of …
2024
2 atıf
Journal of cosmetic …
2023
8 atıf
Clinical, cosmetic and …
2023
3 atıf
Dermatology and therapy
2022
43 atıf
Archives of dermatological …
2022
16 atıf
Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata.
RCT
The Journal of …
2022
9 atıf
Dermatologic therapy
2022
9 atıf
Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report.
Case Report
Frontiers in immunology
2022
8 atıf
Dermatologic therapy
2022
8 atıf
International journal of …
2022
1 atıf
Aesthetic plastic surgery
2021
8 atıf
Dermatologic therapy
2021
7 atıf
Clinical and experimental …
2020
27 atıf
Acta dermatovenerologica Alpina, …
2020
24 atıf
Journal of the …
2020
10 atıf
Proceedings (Baylor University. …
2020
8 atıf
Successful Treatment of Alopecia Areata Patches with Triamcinolone Acetonide Using MMP®: Report of 2 Cases.
Case Report
Skin appendage disorders
2020
6 atıf
Cureus
2019
18 atıf
Journal of cosmetic …
2019
14 atıf
Journal of the …
2018
114 atıf
The journal of …
2018
25 atıf
The Journal of …
2017
1 atıf
Journal of cutaneous …
2014
80 atıf
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
Yaygın Kullanılan Dozajlar
- hairloss:
- 1.5 mm depth, weekly sessions
Üst sınır: Not applicable
Araştırmalarda İncelenen Dozajlar
| Dozaj | Süre | Etki | N |
|---|---|---|---|
| variable; exosomes predominantly from mesenchymal stem cells (MSCs) | -- | Positive | 16 |
| Concentrated growth factor (CGF) combined with microneedling-assisted compound betamethasone; multip | -- | Positive | 7 |
| None | -- | Mixed | -- |
| Fractional radiofrequency microneedling (FRM), 6 sessions with 3-week intervals | 18 weeks | Neutral | 24 |
| Various microtrauma procedures: microneedling, fractional/non-fractional lasers, contact immunothera | -- | Positive | -- |
| Halometasone topical applied every 2 days for 2 weeks after hand-held dermal microneedling treatment | 2 weeks | Positive | -- |
| Microinfusion of medications into the skin (MMP) using tattoo devices; various drugs (minoxidil, ste | -- | Positive | -- |
| Melatonin 3 mg/kg; PBM diode laser 660nm, 100mW, 3 J/point, 2 sessions/week | 12 weeks | Mixed | 60 |
En iyi alım zamanı: Weekly sessions; avoid minoxidil for 24 hours post-treatment
Safety & Side Effects
Bildirilen Yan Etkiler
- ⚠ Scalp redness and inflammation (24-72 hours)
- ⚠ Mild bleeding at treatment site
- ⚠ Scalp tenderness and soreness
- ⚠ Rare: infection if proper sterilization not maintained
Bilinen Etkileşimler
- ● Topical minoxidil (enhanced absorption; wait 24 hours after microneedling to apply)
- ● Blood thinners (may increase bleeding during procedure)
- ● Topical retinoids (discontinue 3-5 days before treatment)
Tolere edilebilir üst alım: Not applicable
Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.
Frequently Asked Questions
Does Mikroiğneleme help with Alopecia Areata?
Based on 34 studies with 1,908 participants, there is strong evidence from multiple clinical trials that Mikroiğneleme may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Mikroiğneleme should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 1.5 mm depth, weekly sessions. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Mikroiğneleme?
Reported side effects may include Scalp redness and inflammation (24-72 hours), Mild bleeding at treatment site, Scalp tenderness and soreness, Rare: infection if proper sterilization not maintained. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Mikroiğneleme and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 34 peer-reviewed studies with 1,908 total participants. The overall direction of effect is positive.
Related Evidence
Şu durum için diğer içerikler: Alopecia Areata
Mikroiğneleme diğer sağlık durumları için
FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.